StemCells Regains Compliance for Continued NASDAQ Global Market Listing
News Jul 22, 2011
StemCells, Inc., has announced that it has received notification from The NASDAQ Stock Market that the Company has regained compliance with the minimum bid price requirement.
In order to continue listing on the NASDAQ Global Market, the NASDAQ Listing Rules require the Company’s stock to evidence a closing of bid price of $1.00 per share or more for ten consecutive days.
On July 20, 2011, the closing bid price of the Company’s common stock was $3.75 per share, the tenth consecutive day the bid price closed above $1.00 per share.
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
International Conference on Hepatology and Liver Diseases
Jun 10 - Jun 11, 2019